| Financial Year |
March 31 2023 |
| Monetary Funds |
674,606,317.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
447,033,769.10 |
| Advances to Suppliers |
47,364,377.60 |
| Other Receivables |
18,970,060.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
316,276,813.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,412,914.33 |
| Total Current Assets |
1,621,436,099.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,698,681.38 |
| Fixed Assetes |
173,570,354.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,039,316.45 |
| R&D expenses |
70,513,353.65 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
55,892.34 |
| Deferred Income Tax Assets |
33,707,035.51 |
| Other Non-Current Assets |
170,158,511.01 |
| Sub-Total of Non-Current Assets |
499,723,765.33 |
| Total Assets |
2,121,159,864.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
432,831,351.89 |
| Accounts Received In Advance |
79,492.07 |
| Employee Compensation Payable |
17,283,283.32 |
| Taxes Payable |
2,435,046.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,326,530.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
91,355.07 |
| Other Current Liabilities |
1,062,334.76 |
| Sub-Total of Current Liabilities |
667,823,105.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,036,964.98 |
| Deferred Income Tax Liabilities |
2,369,816.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,495,246.22 |
| Total Liabilities |
727,318,351.91 |
| Paid-In Capital(Or Share Stock) |
408,548,455.00 |
| Capital Surplus |
294,895,188.58 |
| Surplus Reserve |
93,583,361.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
596,774,507.26 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,393,841,512.51 |
| Owner's Equity（Stockholder's Equity） |
1,393,841,512.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,121,159,864.42 |
